Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CALGB 150905 (Alliance): Rituximab broadens the antilymphoma response by activating unlicensed NK cells
    Journal Article

    Du, J.; Lopez-Verges, S.; Pitcher, B. N.; Johnson, J.; Jung, S. H.; Zhou, L. L.; Hsu, K.; Czuczman, M. S.; Cheson, B.; Kaplan, L.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Phenotypic and functional activation of hyporesponsive KIR(neg)NKG2A(neg) human NK-cell precursors requires IL12p70 provided by poly(I:C)-matured monocyte-derived dendritic cells
    Journal Article

    Curran, S. A.; Romano, E.; Kennedy, M. G.; Hsu, K. C.; Young, J. W.
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
    Journal Article

    Venneti, S.; Santi, M.; Felicella, M. M.; Yarilin, D.; Phillips, J. J.; Sullivan, L. M.; Martinez, D.; Perry, A.; Lewis, P. W.; Thompson, C. B.; more...
    Acta Neuropathologica (2014)

    Fulltext@MSK | Save
  • Advances in the surgical treatment of neuroblastoma: A review
    Journal Article

    Murphy, J. M.; La Quaglia, M. P.
    European Journal of Pediatric Surgery (2014)

    Fulltext@MSK | Save
  • Advances in fibrolamellar hepatocellular carcinoma: A review
    Journal Article

    Lim, I. I. P.; Farber, B. A.; LaQuaglia, M. P.
    European Journal of Pediatric Surgery (2014)

    Fulltext@MSK | Save
  • Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
    Journal Article

    Hultcrantz, M.; Pfeiffer, R. M.; Björkholm, M.; Goldin, L. R.; Turesson, I.; Schulman, S.; Landgren, O.; Kristinsson, S. Y.
    Journal of Thrombosis and Haemostasis (2014)

    Fulltext@MSK | Save
  • Predicting outcome in patients with rhabdomyosarcoma: Role of [18F]fluorodeoxyglucose positron emission tomography
    Journal Article

    Casey, D. L.; Wexler, L. H.; Fox, J. J.; Dharmarajan, K. V.; Schoder, H.; Price, A. N.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Large-scale clinical grade retroviral vector production using a fixed-bed bioreactor
    Meeting Abstract

    Wang, X. Y.; Olszewska, M.; Qu, J. R.; Wasielewska, T.; Hermetet, G.; Sadelain, M.; Riviere, I.
    Human Gene Therapy (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma
    Journal Article

    Tannir, N. M.; Forero-Torres, A.; Ramchandren, R.; Pal, S. K.; Ansell, S. M.; Infante, J. R.; de Vos, S.; Hamlin, P. A.; Kim, S. K.; Whiting, N. C.; more...
    Investigational New Drugs (2014)

    Fulltext@MSK | Save